爱威科技股份有限公司关于取得专利证书、软件著作权登记证书及医疗器械备案凭证的自愿性披露公告

Core Points - The company has obtained a total of 4 domestic patent certificates, including 2 invention patents and 2 design patents, as well as 2 foreign patents, 3 computer software copyright registration certificates, and 1 Class I medical device filing certificate from July 1, 2025, to September 30, 2025 [1][2][3] Group 1: Patent Certificates - The acquisition of the patents reflects the company's core technology and will enhance its intellectual property protection system, promoting technological innovation and improving core competitiveness [1][2] - The recent patent acquisitions are not expected to have a significant impact on the company's short-term operations [1][2] Group 2: Computer Software Copyright - The obtained computer software copyright registration certificates will help enhance the company's core competitiveness and support the establishment of a continuous innovation mechanism [2] Group 3: Medical Device Filing - The Class I medical device filing certificate will diversify the company's product offerings and meet market demand, thereby strengthening its core competitiveness [3] - The sales performance of the products post-launch will depend on future market promotion efforts, and the company cannot currently predict the specific impact on future revenue [3]